Systemic Lupus Erythematosus revealed by Libman-Sacks Endocarditis: A Case Report
Published: 2023-04-19
Page: 94-98
Issue: 2023 - Volume 6 [Issue 1]
Asmaa Elamraoui *
Cardiology Department, CHU Ibn Rochd, N°1 quartier des Hopitaux-24200, Casablanca, Morocco.
Adam Fadoul
Cardiology Department, CHU Ibn Rochd, N°1 quartier des Hopitaux-24200, Casablanca, Morocco.
Yousra Hamine
Cardiology Department, CHU Ibn Rochd, N°1 quartier des Hopitaux-24200, Casablanca, Morocco.
Ghali Bennouna
Cardiology Department, CHU Ibn Rochd, N°1 quartier des Hopitaux-24200, Casablanca, Morocco.
Leila Azzouzi
Cardiology Department, CHU Ibn Rochd, N°1 quartier des Hopitaux-24200, Casablanca, Morocco.
Abdenasser Drighil
Cardiology Department, CHU Ibn Rochd, N°1 quartier des Hopitaux-24200, Casablanca, Morocco.
Rachida Habbal
Cardiology Department, CHU Ibn Rochd, N°1 quartier des Hopitaux-24200, Casablanca, Morocco.
*Author to whom correspondence should be addressed.
Abstract
Libman-Sacks endocarditis (LSE) is a rare cardiovascular manifestation of systemic lupus erythematosus and has been described as an aseptic verrucous non-bacterial autonomic disease. Theselesions can cause progressive damage to heart valves and may need surgery. The aortic and mitral valves are the most commonly affected valves. The majority of LSE patients are usually asymptomatic. Case overview, we describe a 29-year-old women patient who presented with dyspnea, increased pulmonary congestion and severe mitral regurgitation with vegetation revealed by transthoracic echocardiography and was diagnosed as Libman-Sacks endocarditis after laboratary test including blood cultures, autoimmune profile, and testing for hypercoagulability.
Keywords: Libman-sacks endocarditis, systemic lupus erythematous, hypercoagulability